Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Health services and systems news

Show

From To
Naltrexone implants provide better HIV treatment outcomes for those with HIV and opioid addiction in Russia

A double-blind, placebo-controlled randomised trial conducted in Russia found that slow-release naltrexone implants resulted in better HIV treatment outcomes for people living with HIV and opioid dependence when compared

Published
19 April 2019
By
Krishen Samuel
Gilead's first big TV push for triple combo Biktarvy showcases HIV diversity

Gilead Sciences wanted to represent the wide range of people living with HIV in its first national TV campaign for Biktarvy. So they chose black, Latino, male, female, gay, bisexual and transgender actors for an ad that encourages people with HIV to “keep being you.”

Published
18 April 2019
From
FiercePharma
Letter to FDA Regarding Application for Descovy as Pre-Exposure Prophylaxis for HIV

TAG and PrEP4All sent this letter to Dr. Debra Birnkrant of the FDA, outlining and expressing our serious concerns about Gilead’s supplemental New Drug Application for Descovy (FTC/TAF) as HIV-1 preexposure prophylaxis (PrEP). There are several specific recommendations in the letter for this approval process, including recomending that the FDA convene a public meeting of the Antiviral Drug Advisory Committee.

Published
17 April 2019
From
Treatment Action Group
Long-Acting HIV Treatment Is Coming. Our Health Care System Needs to Prepare

New conversations are starting in HIV care as phase III trials have shown that monthly injections of cabotegravir and rilpivirine (Edurant) are non-inferior to a three-drug pill regimen. In 2018, TheBody asked a range of people living with HIV about their willingness to switch to an injectible, and most had mixed feelings. But even if there's widespread interest in this new way of taking antiretroviral therapy (and most likely also prevention, not too far away), it's important to consider not just the willingness of people to move to this new form of treatment, but whether health care systems and providers in the U.S. are ready to support this innovation.

Published
16 April 2019
From
The Body Pro
Arizona Repeals “No Promo Homo” Law That Hindered HIV Education

The anti-LGBT law barred students from getting medically accurate information about safe sex.

Published
16 April 2019
From
Poz
Venezuela Falls Under The Triple Attack of HIV, Tuberculosis And Malaria

A little over a year later, the situation is a lot more serious than we originally foresaw. Every health, poverty, nutrition, economic growth and social development index in Venezuela has loudly worsened, while the Venezuelan government keeps on denying not only the existence of the humanitarian crisis affecting the country but even worse, the entrance of humanitarian aid.

Published
16 April 2019
From
Caracas Chronicles
“Dialogue” Highlighted As Way Forward At Closure Of WHO Fair Pricing Forum

WHO said that it will launch a public online consultation involving governments, industry and civil society to try to come up with a broad consensus on what actually constitutes a “fair price” for essential medicines.

Published
15 April 2019
From
Health Policy Watch
UN Whistleblower Targeted in Misconduct Probe

Confidential documents obtained by The Associated Press show UNAIDS is grappling with previously unreported allegations of financial and sexual misconduct involving Martina Brostrom, who went public last March with claims that one of the organization's top officials assaulted her in 2015. As part of a preliminary internal inquiry, investigators for the World Health Organization, which oversees UNAIDS, wrote that they had found "evidence" that Brostrom and her former supervisor may have taken part in "fraudulent practices and misuse of travel funds," the documents show.

Published
15 April 2019
From
U.S. News and World Report
Will new TB treatments reach those who need them most?

Pharma giant GlaxoSmithKline is pursuing new treatments for tuberculosis but insists it will need support from governments and funding agencies if it is to get them to patients in lower-income countries, the head of its global health unit, David Barros-Aguirre, told Devex.

Published
15 April 2019
From
Devex
Tackling the high price of medicine

Profit seems to be the only logic driving medicine prices, with some African countries paying more for medicine than European countries, and US citizens paying some of the highest medicine prices in the world. While there are global efforts to rein in pharmaceutical companies’ excessive profiteering from sickness, trying to remove the secrecy around prices is complicated.

Published
15 April 2019
From
Daily Maverick
← First12345...722Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.